Glizest-M 60/500 SR Tablet

Gliclazide 60 mg + Metformin 500 mg

Glizest-M 60/500 SR Tablet — Gliclazide 60 mg + Metformin 500 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Gliclazide 60 mg + Metformin 500 mg
Dosage Form Tablet
Pack Type Box
Pack Size 10 x 10 (Blister)
MRP ₹ 790
Therapy Cardiac + Diabetic — Second-generation sulphonylurea (Gliclazide-based)
Storage Store below 25°C.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Glizest-M 60/500 SR Tablet

Glizest-M 60/500 SR Tablet contains Gliclazide 60 mg + Metformin 500 mg. Gliclazide is a second-generation sulphonylurea with additional antioxidant and antiplatelet properties — making it particularly useful in type-2 diabetic patients with cardiovascular risk.

Indicated for adult type-2 diabetes mellitus inadequately controlled by lifestyle measures alone or in combination with metformin / other oral agents.

Camrut Healthcare manufactures the Glizest range under WHO-GMP conditions for PCD pharma franchise across India.

Indications

  • Type-2 diabetes mellitus
  • Adjunct to metformin
  • Diabetic patients with vascular risk (gliclazide's antioxidant benefit)

Mechanism of Action

Gliclazide is a second-generation sulphonylurea that stimulates pancreatic beta-cell insulin secretion by closing ATP-sensitive K+ channels (SUR1). It also has antioxidant and antiplatelet effects via free-radical scavenging and reduced platelet aggregation — providing additional benefit in diabetic vascular complications.

Dosage & Administration

['Adults: 1 tablet once daily before breakfast (or as advised)', 'Titrate based on glycaemic response', 'Maximum 320 mg/day total gliclazide', 'MR tablets: swallow whole, do not crush']

Side Effects

['Hypoglycaemia', 'Weight gain (mild)', 'GI upset', 'Skin reactions (rare)', 'Cholestatic jaundice (rare)']

Contraindications & Precautions

['Type-1 diabetes', 'Diabetic ketoacidosis', 'Severe hepatic/renal impairment', 'Pregnancy and breastfeeding', 'Sulphonamide hypersensitivity']

Storage

Store below 25°C.

PCD Pharma Franchise & Third-Party Manufacturing
Glizest-M 60/500 SR Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.